Article
Evaluation of the Available Variant Calling Tools for Oxford Nanopore Sequencing in Breast Cancer.
Genes - 3 Sept 2022
Helal Asmaa A, Saad Bishoy T, Saad Mina T, Mosaad Gamal S, Aboshanab Khaled M
Abstract excerpt
The goal of biomarker testing, in the field of personalized medicine, is to guide treatments to achieve the best possible results for each patient. The accurate and reliable identification of everyone's genome variants is essential for the success of clinical genomics, employing third-generation sequencing. Different variant calling techniques have been used and recommended by both Oxford Nanopore Technologies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
